Published in J Crohns Colitis on December 06, 2008
Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol (2013) 1.75
Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr (2015) 1.07
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol (2016) 0.87
Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm Bowel Dis (2014) 0.86
Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2014) 0.85
Dietary fructose intolerance, fructan intolerance and FODMAPs. Curr Gastroenterol Rep (2014) 0.84
Nutritional management of Crohn's disease. Therap Adv Gastroenterol (2013) 0.84
Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis (2015) 0.82
Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol (2016) 0.82
Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial. Nutr J (2015) 0.81
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol (2016) 0.81
Diet therapy for inflammatory bowel diseases: The established and the new. World J Gastroenterol (2016) 0.80
Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. Int J Mol Sci (2016) 0.79
Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum". Int J Inflam (2012) 0.79
Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol (2016) 0.79
The Low FODMAP Diet for Treatment of Irritable Bowel Syndrome and Other Gastrointestinal Disorders. Gastroenterol Hepatol (N Y) (2013) 0.78
Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol (2016) 0.78
Candidate genes involved in beneficial or adverse responses to commonly eaten brassica vegetables in a New Zealand Crohn's disease cohort. Nutrients (2013) 0.78
Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J (2016) 0.77
Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. World J Gastroenterol (2015) 0.76
Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease. Int J Mol Sci (2016) 0.76
Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire. Nutr J (2015) 0.76
The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res (2017) 0.75
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol (2016) 0.75
A survey of people with inflammatory bowel disease to investigate their views of food and nutritional issues. Eur J Clin Nutr (2016) 0.75
Diet and Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2015) 0.75
An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease. Nutrients (2017) 0.75
The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75
Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75
Influence of Diet on the Course of Inflammatory Bowel Disease. Dig Dis Sci (2017) 0.75
Eosinophilic esophagitis: What can we learn from Crohn's disease? United European Gastroenterol J (2016) 0.75
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol (2011) 5.66
No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology (2013) 4.52
Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol (2008) 3.33
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol (2010) 2.52
The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol (2010) 1.93
Issues associated with the emergence of coeliac disease in the Asia–Pacific region: a working party report of the World Gastroenterology Organization and the Asian Pacific Association of Gastroenterology. J Gastroenterol Hepatol (2014) 1.83
Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust (2010) 1.78
Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc (2006) 1.77
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr (2012) 1.51
Strategies to manage gastrointestinal symptoms complicating enteral feeding. JPEN J Parenter Enteral Nutr (2008) 1.50
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut (2013) 1.37
Pathogenesis of colonic diverticulosis: repainting the picture. Clin Gastroenterol Hepatol (2013) 1.24
Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol (2013) 1.23
Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol (2006) 1.18
Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach. J Gastroenterol Hepatol (2006) 1.11
Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.05
Infections and IBD. Nat Clin Pract Gastroenterol Hepatol (2008) 1.04
Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem (2007) 1.03
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? Therap Adv Gastroenterol (2012) 1.01
Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol (2006) 1.01
Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem (2009) 0.99
Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol (2008) 0.99
Not all effects of a gluten-free diet are due to removal of gluten. Gastroenterology (2013) 0.98
Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index. J Am Diet Assoc (2010) 0.97
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential. J Immunol (2011) 0.96
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol (2014) 0.95
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all. Clin Gastroenterol Hepatol (2010) 0.95
Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol (2010) 0.94
Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.93
The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders. Nutrition (2010) 0.92
Optimization of conventional therapy in patients with IBD. Nat Rev Gastroenterol Hepatol (2011) 0.92
Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol. J Crohns Colitis (2012) 0.92
Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics. Eur J Gastroenterol Hepatol (2006) 0.90
Venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol (2013) 0.90
The influence of specific luminal factors on the colonic epithelium: high-dose butyrate and physical changes suppress early carcinogenic events in rats. Dis Colon Rectum (2005) 0.88
"Diversion" colitis caused by Clostridium difficile infection: report of a case. Dis Colon Rectum (2006) 0.88
Hair loss in patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.87
Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis (2007) 0.84
5-Aminosalicylic acid (mesalazine) use in Crohn's disease: a survey of the opinions and practice of Australian gastroenterologists. Inflamm Bowel Dis (2007) 0.83
Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysis. Eur J Gastroenterol Hepatol (2012) 0.83
A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. J Gastroenterol Hepatol (2007) 0.83
Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders. Am J Gastroenterol (2013) 0.83
Semiquantitative assessment of breath hydrogen testing. J Gastroenterol Hepatol (2013) 0.82
Alopecia areata: a possible extraintestinal manifestation of Crohn's disease. J Crohns Colitis (2013) 0.82
Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease. Inflamm Bowel Dis (2015) 0.81
Fructose malabsorption syndrome. Curr Opin Clin Nutr Metab Care (2013) 0.81
Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: safe alternative to surgery. J Gastroenterol Hepatol (2007) 0.81
Factors associated with physical and cognitive fatigue in patients with Crohn's disease: a cross-sectional and longitudinal study. Inflamm Bowel Dis (2014) 0.81
The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders. Int J Rheum Dis (2014) 0.80
Colonic epithelial atrophy induced by a fibre-free diet in rats is reversed by minimal amounts of luminal butyrate, but only in the short term. ANZ J Surg (2002) 0.80
Is gluten a cause of gastrointestinal symptoms in people without celiac disease? Curr Allergy Asthma Rep (2013) 0.79
Hidradenitis suppurativa: MRI features in anogenital disease. Dis Colon Rectum (2014) 0.79
The trophic effect of dietary fibre is not associated with a change in total crypt number in the distal colon of rats. Carcinogenesis (2003) 0.78
Fructose and lactose testing. Aust Fam Physician (2012) 0.78
The Low FODMAP Diet for Treatment of Irritable Bowel Syndrome and Other Gastrointestinal Disorders. Gastroenterol Hepatol (N Y) (2013) 0.78
Failure of gastroenterologists to apply intestinal ultrasound in inflammatory bowel disease in the Asia-Pacific: a need for action. J Gastroenterol Hepatol (2015) 0.77
Thiopurines, a previously unrecognised cause for fatigue in patients with inflammatory bowel disease. J Crohns Colitis (2009) 0.77
Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: 'a cocktail best avoided, not stirred'. J Crohns Colitis (2011) 0.77
Optimizing conventional therapies for inflammatory bowel disease. Curr Gastroenterol Rep (2009) 0.76
Optimizing thiopurine therapy: more weight to the metabolite argument. J Gastroenterol Hepatol (2010) 0.76
Toxicity and response to thiopurines in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol (2015) 0.76
Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to? J Gastroenterol Hepatol (2009) 0.75
Leukocytapheresis in ulcerative colitis. Am J Gastroenterol (2006) 0.75
Alternative investigations for irritable bowel syndrome. J Gastroenterol Hepatol (2013) 0.75
For celiac disease, diagnosis is not enough. Clin Gastroenterol Hepatol (2012) 0.75
Outcome of peptic ulcer bleeding. Clin Gastroenterol Hepatol (2006) 0.75
Diverticular disease of the colon. Lancet (2004) 0.75
Infliximab: getting the most for your money. J Gastroenterol Hepatol (2007) 0.75
Response to Comment on low FODMAP diet. Nutr Clin Pract (2013) 0.75
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. Gastroenterol Hepatol (N Y) (2008) 0.75
The challenges of control groups, placebos and blinding in clinical trials of dietary interventions. Proc Nutr Soc (2017) 0.75
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel. Inflamm Bowel Dis (2016) 0.75
Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's Disease. Inflamm Bowel Dis (2017) 0.75
Distinct management issues with Crohn's disease of the small intestine. Curr Opin Gastroenterol (2015) 0.75
Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C. J Gastroenterol Hepatol (2005) 0.75
Development of a chronic colonic intubation model in rats for the study of luminal factors in colonic diseases. Dis Colon Rectum (2002) 0.75